Hearing Loss, Sensorineural Clinical Trial
Official title:
A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Multicenter Study to Evaluate the Efficacy of FX-322 Administered by Intratympanic Injection in Adults With Acquired Sensorineural Hearing Loss
This is a Phase 2, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter study to evaluate the efficacy of FX-322, administered by intratympanic injection, in adults with acquired sensorineural hearing loss (SNHL).
This is a Phase 2, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter study to evaluate the efficacy of FX-322, administered by intratympanic injection, in adults with acquired sensorineural hearing loss (SNHL). Previous human studies in subjects 18 to 65 years inclusive (FX-322-103, FX-322-201, FX-322-111) and subjects 66-85 inclusive (FX-322-112) demonstrated that a single dose FX-322 was well tolerated in patients with acquired SNHL with no treatment-related serious adverse events. Adverse events in these studies were generally common to and associated with the intratympanic injection procedure with mild and transient discomfort in patients both with the drug and the placebo. Frequency Therapeutics' Investigators intend to evaluate efficacy with a single dose of FX-322 in subjects 18 to 65 years inclusive with acquired SNHL. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04281953 -
Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
|
||
Not yet recruiting |
NCT05973669 -
MED-EL Remote Care Multi-Center Feasibility Study
|
N/A | |
Completed |
NCT04601909 -
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
|
Phase 1 | |
Active, not recruiting |
NCT04479761 -
Sensory Integration of Auditory and Visual Cues in Diverse Contexts
|
N/A | |
Recruiting |
NCT05043207 -
A Study Protocol for the Validation of UAud in a Clinical Setting.
|
N/A | |
Recruiting |
NCT04066270 -
Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
|
||
Recruiting |
NCT04070937 -
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
|
||
Completed |
NCT03512951 -
Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception
|
N/A | |
Completed |
NCT05855005 -
Direct-to-Consumer Hearing Aids and Listening Effort
|
N/A | |
Recruiting |
NCT05599165 -
Speech Perception in Bimodal Hearing
|
N/A | |
Completed |
NCT05101083 -
Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
|
N/A | |
Completed |
NCT05521308 -
Investigating Hearing Aid Frequency Response Curves
|
N/A | |
Completed |
NCT05072457 -
Benefit of Assistive Listening Device for Lateralization
|
N/A | |
Recruiting |
NCT05776459 -
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
|
Phase 2 | |
Recruiting |
NCT06058767 -
Preschool Hearing Screening
|
N/A | |
Completed |
NCT05180630 -
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
|
N/A | |
Completed |
NCT03613909 -
Acceptance of the CP950 Sound Processor
|
N/A | |
Active, not recruiting |
NCT03352154 -
Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants
|
N/A | |
Completed |
NCT04629664 -
FX-322 in Adults With Severe Sensorineural Hearing Loss
|
Phase 1 | |
Completed |
NCT05052944 -
Single-sided Deafness and Cochlear Implantation
|